Skip to main content

Peer Review reports

From: Comparison of three doses of amikacin on alternate days with a daily dose of meropenem during the same period for the treatment of urinary tract infection with E. coli: a double-blind clinical trial

Original Submission
18 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Jul 2023 Author responded Author comments - Amjad Ahmadi
Resubmission - Version 3
29 Jul 2023 Submitted Manuscript version 3
25 Aug 2023 Reviewed Reviewer Report
9 Sep 2023 Author responded Author comments - Amjad Ahmadi
Resubmission - Version 4
9 Sep 2023 Submitted Manuscript version 4
26 Sep 2023 Reviewed Reviewer Report - Jalal Mardaneh
26 Sep 2023 Reviewed Reviewer Report
18 Oct 2023 Author responded Author comments - Amjad Ahmadi
Resubmission - Version 5
18 Oct 2023 Submitted Manuscript version 5
10 Nov 2023 Author responded Author comments - Amjad Ahmadi
Resubmission - Version 6
10 Nov 2023 Submitted Manuscript version 6
13 Nov 2023 Author responded Author comments - Amjad Ahmadi
Resubmission - Version 7
13 Nov 2023 Submitted Manuscript version 7
29 Nov 2023 Author responded Author comments - Amjad Ahmadi
Resubmission - Version 8
29 Nov 2023 Submitted Manuscript version 8
Publishing
5 Dec 2023 Editorially accepted
25 Jan 2024 Article published 10.1186/s13104-023-06654-y

You can find further information about peer review here.

Back to article page